Singapore markets close in 2 hours 15 minutes

Genmab A/S (GE9.DE)

XETRA - XETRA Delayed price. Currency in EUR
Add to watchlist
331.000.00 (0.00%)
At close: 05:35PM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
17,783,000
16,474,000
14,505,000
8,417,000
10,111,000
-
Cost of revenue
411,000
226,000
0
0
-
-
Gross profit
17,372,000
16,248,000
14,505,000
8,417,000
-
-
Operating expenses
Research development
8,189,000
7,630,000
5,562,000
4,181,000
3,137,000
-
Selling general and administrative
3,478,000
3,297,000
2,676,000
1,283,000
661,000
-
Total operating expenses
11,667,000
10,927,000
8,238,000
5,464,000
3,798,000
-
Operating income or loss
5,705,000
5,321,000
6,267,000
2,953,000
6,313,000
-
Interest expense
28,000
27,000
21,000
13,000
10,000
-
Total other income/expenses net
368,000
-596,000
375,000
781,000
-583,000
-
Income before tax
7,087,000
5,637,000
6,945,000
3,918,000
5,904,000
-
Income tax expense
1,620,000
1,285,000
1,493,000
961,000
1,146,000
-
Income from continuing operations
5,467,000
4,352,000
5,452,000
2,957,000
4,758,000
-
Net income
5,467,000
4,352,000
5,452,000
2,957,000
4,758,000
-
Net income available to common shareholders
5,467,000
4,352,000
5,452,000
2,957,000
4,758,000
-
Basic EPS
-
-
-
-
73.00
34.40
Diluted EPS
-
-
-
-
72.21
34.03
Basic average shares
-
-
-
-
65,179
62,963
Diluted average shares
-
-
-
-
65,886
63,637